Sino Biopharmaceutical (1177.HK) - EPS (earnings per share)

EPS in 2021 (TTM): A$0.04960

According to Sino Biopharmaceutical's latest financial reports the company's current EPS (TTM) is A$0.04965. In 2024 the company made an earnings per share (EPS) of A$0.03643 an increase over its 2023 EPS that were of A$0.02475.

EPS history for Sino Biopharmaceutical from 1999 to 2021

Annual EPS

Year	EPS	Change
2024	A$0.03643	47.17%
2023	A$0.02475	-9.68%
2022	A$0.02741	-83.86%
2021	A$0.17	440.46%
2020	A$0.03141	7.54%
2019	A$0.02921	-70.37%
2018	A$0.09857	254.37%
2017	A$0.02781	41.55%
2016	A$0.01965	2.59%
2015	A$0.01915	17.63%
2014	A$0.01628	45.97%
2013	A$0.01116	16.34%
2012	A$0.009588	93.4%
2011	A$0.004958	-20.02%
2010	A$0.006199	33.16%
2009	A$0.004655	774.72%
2008	A$0.0005322	-79.69%
2007	A$0.002621	58.8%
2006	A$0.001650	-91.05%
2005	A$0.01843	723.97%
2004	A$0.002237	105.48%
2003	A$0.001089	-67.27%
2002	A$0.003326	-8.26%
2001	A$0.003626	17.18%
2000	A$0.003094	-2.81%
1999	A$0.003184

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

EPS for Sino Biopharmaceutical (1177.HK)